319 related articles for article (PubMed ID: 28685321)
1. Targeting FGFR in Squamous Cell Carcinoma of the Lung.
Hashemi-Sadraei N; Hanna N
Target Oncol; 2017 Dec; 12(6):741-755. PubMed ID: 28685321
[TBL] [Abstract][Full Text] [Related]
2. [Progress on the Study of Targeting FGFR in Squamous Non-small Cell Lung Cancer].
Dong M; Li T; Chen J
Zhongguo Fei Ai Za Zhi; 2018 Feb; 21(2):116-120. PubMed ID: 29526179
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast Growth Factor Receptor (FGFR): A New Target for Non-small Cell Lung Cancer Therapy.
Biello F; Burrafato G; Rijavec E; Genova C; Barletta G; Truini A; Coco S; Bello MG; Alama A; Boccardo F; Grossi F
Anticancer Agents Med Chem; 2016; 16(9):1142-54. PubMed ID: 26845137
[TBL] [Abstract][Full Text] [Related]
4. Role of FGF receptors as an emerging therapeutic target in lung squamous cell carcinoma.
Lim SM; Kim HR; Shim HS; Soo RA; Cho BC
Future Oncol; 2013 Mar; 9(3):377-86. PubMed ID: 23469973
[TBL] [Abstract][Full Text] [Related]
5. Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer.
Rijavec E; Genova C; Barletta G; Biello F; Rossi G; Tagliamento M; Dal Bello MG; Coco S; Vanni I; Boccardo S; Alama A; Grossi F
Expert Opin Investig Drugs; 2017 May; 26(5):551-561. PubMed ID: 28388262
[TBL] [Abstract][Full Text] [Related]
6. FGFR Signaling as a Target for Lung Cancer Therapy.
Desai A; Adjei AA
J Thorac Oncol; 2016 Jan; 11(1):9-20. PubMed ID: 26762735
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast Growth Factor (FGF) Receptor/FGF Inhibitors: Novel Targets and Strategies for Optimization of Response of Solid Tumors.
Hierro C; Rodon J; Tabernero J
Semin Oncol; 2015 Dec; 42(6):801-19. PubMed ID: 26615127
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications.
Helsten T; Schwaederle M; Kurzrock R
Cancer Metastasis Rev; 2015 Sep; 34(3):479-96. PubMed ID: 26224133
[TBL] [Abstract][Full Text] [Related]
9. Recent developments and advances of FGFR as a potential target in cancer.
Xue WJ; Li MT; Chen L; Sun LP; Li YY
Future Med Chem; 2018 Sep; 10(17):2109-2126. PubMed ID: 30066580
[TBL] [Abstract][Full Text] [Related]
10. FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib.
Hibi M; Kaneda H; Tanizaki J; Sakai K; Togashi Y; Terashima M; De Velasco MA; Fujita Y; Banno E; Nakamura Y; Takeda M; Ito A; Mitsudomi T; Nakagawa K; Okamoto I; Nishio K
Cancer Sci; 2016 Nov; 107(11):1667-1676. PubMed ID: 27581340
[TBL] [Abstract][Full Text] [Related]
11. FGFR as potential target in the treatment of squamous non small cell lung cancer.
Tiseo M; Gelsomino F; Alfieri R; Cavazzoni A; Bozzetti C; De Giorgi AM; Petronini PG; Ardizzoni A
Cancer Treat Rev; 2015 Jun; 41(6):527-39. PubMed ID: 25959741
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor signaling and inhibition in non-small cell lung cancer and their role in squamous cell tumors.
Salgia R
Cancer Med; 2014 Jun; 3(3):681-92. PubMed ID: 24711160
[TBL] [Abstract][Full Text] [Related]
13. Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors.
Dienstmann R; Rodon J; Prat A; Perez-Garcia J; Adamo B; Felip E; Cortes J; Iafrate AJ; Nuciforo P; Tabernero J
Ann Oncol; 2014 Mar; 25(3):552-563. PubMed ID: 24265351
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the FGF/FGFR System Induces Apoptosis in Lung Cancer Cells via c-Myc Downregulation and Oxidative Stress.
Giacomini A; Taranto S; Rezzola S; Matarazzo S; Grillo E; Bugatti M; Scotuzzi A; Guerra J; Di Trani M; Presta M; Ronca R
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33317057
[TBL] [Abstract][Full Text] [Related]
15. Targeting FGFR Signaling in Cancer.
Touat M; Ileana E; Postel-Vinay S; André F; Soria JC
Clin Cancer Res; 2015 Jun; 21(12):2684-94. PubMed ID: 26078430
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast Growth Factor Receptor Signaling in Skin Cancers.
Czyz M
Cells; 2019 Jun; 8(6):. PubMed ID: 31167513
[TBL] [Abstract][Full Text] [Related]
17. Targeting fibroblast growth factor receptor (FGFR) pathway in renal cell carcinoma.
Massari F; Ciccarese C; Santoni M; Lopez-Beltran A; Scarpelli M; Montironi R; Cheng L
Expert Rev Anticancer Ther; 2015; 15(12):1367-9. PubMed ID: 26568023
[TBL] [Abstract][Full Text] [Related]
18. Targeting the fibroblast growth factor receptor family in cancer.
Hallinan N; Finn S; Cuffe S; Rafee S; O'Byrne K; Gately K
Cancer Treat Rev; 2016 May; 46():51-62. PubMed ID: 27109926
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application.
Chae YK; Ranganath K; Hammerman PS; Vaklavas C; Mohindra N; Kalyan A; Matsangou M; Costa R; Carneiro B; Villaflor VM; Cristofanilli M; Giles FJ
Oncotarget; 2017 Feb; 8(9):16052-16074. PubMed ID: 28030802
[TBL] [Abstract][Full Text] [Related]
20. The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis.
Ronca R; Giacomini A; Rusnati M; Presta M
Expert Opin Ther Targets; 2015; 19(10):1361-77. PubMed ID: 26125971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]